Open Payments

ST JOHN HOSPITAL & MEDICAL CENTER

Type
Teaching hospital
Where
Detroit, MI
Medicare CCN
230165
Received
$595,106 in 126 records, 2021 ($78,001 general, $517,105 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2021General payment8$78,001
2021Research payment118$517,105

By company

CompanyRecordsAmountYears
JAZZ PHARMACEUTICALS INC.1$186,7332021
Medtronic, Inc.30$85,3302021
Genetesis, Inc.7$75,4902021
AngioDynamics, Inc.2$73,0002021
ViiV Healthcare Company15$46,1912021
Abbott Laboratories18$41,9312021
Gilead Sciences, Inc.11$18,7622021
Amgen Inc.1$15,0622021
Penumbra, Inc.10$14,5572021
Bard Peripheral Vascular, Inc.1$10,0002021
Alexion Pharmaceuticals, Inc.2$6,0642021
PFIZER INC.1$4,7502021
RedHill Biopharma Inc.4$3,6842021
Biogen, Inc.1$2,2032021
Stryker Corporation2$2,1062021
Merge Healthcare Incorporated3$1,8942021
Celgene Corporation1$1,8302021
Cardiovascular Systems Inc.3$1,6182021
Pharmacyclics LLC, an AbbVie Company10$1,5802021
Boston Scientific Corporation1$1,3002021
Janssen Pharmaceuticals, Inc1$1,0002021
Eli Lilly and Company1$162021

By nature of payment

NatureRecordsAmount
Research payment118$517,105
Education2$73,000
Long term medical supply or device loan2$2,106
Food and Beverage3$1,894
Space rental or facility fees (teaching hospital only)1$1,000

Records

DateCompanyAmountNatureFormProductStudyYear
2021-12-31AngioDynamics, Inc.$60,000EducationIn-kind items and servicesNanoKnife Device, Oncology Surgery2021
2021-12-31AngioDynamics, Inc.$13,000EducationIn-kind items and servicesSolero Device, Oncology2021
2021-12-22Gilead Sciences, Inc.$883Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-12-16Medtronic, Inc.$262Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-12-16Medtronic, Inc.$262Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-12-09Alexion Pharmaceuticals, Inc.$3,604Research paymentCash or cash equivalentAn Observational Disease and Clinical Outcomes Registry of Patients With Lysosomal Acid Lipase (LAL) Deficiency2021
2021-12-07Genetesis, Inc.$11,760Research paymentCash or cash equivalentACCMED2021
2021-11-29Genetesis, Inc.$11,130Research paymentCash or cash equivalentACCMED2021
2021-11-26Abbott Laboratories$1,000Research paymentCash or cash equivalent Device, Cardiac Rhythm ManagementA safety and effectiveness trial for a leadless pacemaker system2021
2021-11-17Penumbra, Inc.$1,000Research paymentCash or cash equivalentIndigo System Device, Peripheral InterventionSTRIKE2021
2021-11-17Gilead Sciences, Inc.$963Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-11-17Penumbra, Inc.$200Research paymentCash or cash equivalentIndigo System Device, Peripheral InterventionSTRIKE2021
2021-11-17Penumbra, Inc.$200Research paymentCash or cash equivalentIndigo System Device, Peripheral InterventionSTRIKE2021
2021-11-15Boston Scientific Corporation$1,300Research paymentCash or cash equivalentVARIOUS RELEASED ICD FAMILIES Device, Clinical Trial ProductSMART MULTI SITE PACING STUDY2021
2021-11-10Abbott Laboratories$11,100Research paymentCash or cash equivalent Device, Cardiac Rhythm ManagementA safety and effectiveness trial for a leadless pacemaker system2021
2021-11-10Penumbra, Inc.$1,000Research paymentCash or cash equivalentIndigo System Device, Peripheral InterventionSTRIKE2021
2021-11-01Medtronic, Inc.$1,607Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsTAVR Low Risk2021
2021-11-01Medtronic, Inc.$1,607Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsTAVR Low Risk2021
2021-10-27Genetesis, Inc.$11,950Research paymentCash or cash equivalentACCMED2021
2021-10-26Penumbra, Inc.$1,000Research paymentCash or cash equivalentIndigo System Device, Peripheral InterventionSTRIKE2021
2021-10-25Stryker Corporation$1,053Long term medical supply or device loanIn-kind items and servicesISOFLEX LAL Device, PATIENT HANDLING - PH2021
2021-10-25Stryker Corporation$1,053Long term medical supply or device loanIn-kind items and servicesISOFLEX LAL Device, PATIENT HANDLING - PH2021
2021-10-20Medtronic, Inc.$4,815Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsCoreValve SURTAVI2021
2021-10-20Medtronic, Inc.$4,815Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsCoreValve SURTAVI2021
2021-10-20Gilead Sciences, Inc.$1,179Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-10-15ViiV Healthcare Company$1,431Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-10-07Abbott Laboratories$500Research paymentCash or cash equivalent Device, Cardiac Rhythm ManagementA safety and effectiveness trial for a leadless pacemaker system2021
2021-10-07Penumbra, Inc.$200Research paymentCash or cash equivalentIndigo System Device, Peripheral InterventionSTRIKE2021
2021-10-07ViiV Healthcare Company$33Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-10-06Abbott Laboratories$9,000Research paymentCash or cash equivalent Device, Cardiac Rhythm ManagementA safety and effectiveness trial for a leadless pacemaker system2021
2021-10-05Gilead Sciences, Inc.$5,760Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-10-04ViiV Healthcare Company$500Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-09-29Abbott Laboratories$45Research paymentIn-kind items and servicesESPRIT Device, VascularLIFE-BTK2021
2021-09-22Gilead Sciences, Inc.$1,785Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-09-21ViiV Healthcare Company$25Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-09-16Pharmacyclics LLC, an AbbVie Company$158Research paymentCash or cash equivalentIMBRUVICA Drug, ONCOLOGYinformCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)2021
2021-09-13Medtronic, Inc.$2,390Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-09-13Medtronic, Inc.$2,390Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-09-09Abbott Laboratories$250Research paymentCash or cash equivalent Device, Cardiac Rhythm ManagementA safety and effectiveness trial for a leadless pacemaker system2021
2021-08-30Medtronic, Inc.$500Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-08-30Medtronic, Inc.$500Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-08-27Genetesis, Inc.$10,630Research paymentCash or cash equivalentACCMED2021
2021-08-26Merge Healthcare Incorporated$1,174Food and Beverage (4 payments)Cash or cash equivalentPACS Device, Medical Imaging2021
2021-08-23ViiV Healthcare Company$4,885Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-08-23Janssen Pharmaceuticals, Inc$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentXARELTO Drug, Cardiovascular & Metabolism2021
2021-08-18Abbott Laboratories$8,540Research paymentCash or cash equivalent Device, Cardiac Rhythm ManagementA safety and effectiveness trial for a leadless pacemaker system2021
2021-08-11Medtronic, Inc.$3,418Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsCoreValve SURTAVI2021
2021-08-11Medtronic, Inc.$3,418Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsCoreValve SURTAVI2021
2021-07-29Medtronic, Inc.$3,239Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsTAVR Low Risk2021
2021-07-29Medtronic, Inc.$3,239Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsTAVR Low Risk2021
2021-07-29Alexion Pharmaceuticals, Inc.$2,460Research paymentCash or cash equivalentAn Observational Disease and Clinical Outcomes Registry of Patients With Lysosomal Acid Lipase (LAL) Deficiency2021
2021-07-28Penumbra, Inc.$8,000Research paymentCash or cash equivalentIndigo System Device, Peripheral InterventionSTRIKE2021
2021-07-27ViiV Healthcare Company$3,338Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-07-15Pharmacyclics LLC, an AbbVie Company$158Research paymentCash or cash equivalentIMBRUVICA Drug, ONCOLOGYinformCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)2021
2021-07-15Pharmacyclics LLC, an AbbVie Company$158Research paymentCash or cash equivalentIMBRUVICA Drug, ONCOLOGYinformCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)2021
2021-07-01Genetesis, Inc.$10,060Research paymentCash or cash equivalentACCMED2021
2021-06-30Abbott Laboratories$750Research paymentCash or cash equivalent Device, Cardiac Rhythm ManagementA safety and effectiveness trial for a leadless pacemaker system2021
2021-06-23Gilead Sciences, Inc.$1,536Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-06-21Merge Healthcare Incorporated$219Food and Beverage (4 payments)Cash or cash equivalentPACS Device, Medical Imaging2021
2021-06-17Penumbra, Inc.$390Research paymentCash or cash equivalentIndigo System Device, Peripheral InterventionCHEETAH2021
2021-06-15Pharmacyclics LLC, an AbbVie Company$158Research paymentCash or cash equivalentIMBRUVICA Drug, ONCOLOGYinformCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)2021
2021-06-14ViiV Healthcare Company$4,410Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-06-04Medtronic, Inc.$600Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-06-04Medtronic, Inc.$600Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-05-26Abbott Laboratories$1,650Research paymentCash or cash equivalent Device, Cardiac Rhythm ManagementA safety and effectiveness trial for a leadless pacemaker system2021
2021-05-25Abbott Laboratories$1,239Research paymentCash or cash equivalentAbsorb GT1 Device, VascularA Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects2021
2021-05-21RedHill Biopharma Inc.$1,463Research paymentCash or cash equivalentOpaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia: a Randomized, Double-blind, Placebo-Controlled P2021
2021-05-21RedHill Biopharma Inc.$1,330Research paymentCash or cash equivalentOpaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia: a Randomized, Double-blind, Placebo-Controlled P2021
2021-05-21RedHill Biopharma Inc.$665Research paymentCash or cash equivalentOpaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia: a Randomized, Double-blind, Placebo-Controlled P2021
2021-05-21RedHill Biopharma Inc.$226Research paymentCash or cash equivalentOpaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia: a Randomized, Double-blind, Placebo-Controlled P2021
2021-05-20Merge Healthcare Incorporated$500Food and BeverageCash or cash equivalentradiology Device, Medical Imaging2021
2021-05-19Gilead Sciences, Inc.$963Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-05-19Medtronic, Inc.$600Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsTAVR Low Risk2021
2021-05-19Medtronic, Inc.$600Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsTAVR Low Risk2021
2021-05-18Pharmacyclics LLC, an AbbVie Company$158Research paymentCash or cash equivalentIMBRUVICA Drug, ONCOLOGYinformCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)2021
2021-05-18Pharmacyclics LLC, an AbbVie Company$158Research paymentCash or cash equivalentIMBRUVICA Drug, ONCOLOGYinformCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)2021
2021-05-18Eli Lilly and Company$16Research paymentIn-kind items and servicesA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MONO AND COMBINATIO2021
2021-05-17Medtronic, Inc.$1,407Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsTAVR Low Risk2021
2021-05-17Medtronic, Inc.$1,407Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsTAVR Low Risk2021
2021-05-14ViiV Healthcare Company$1,440Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-05-13Medtronic, Inc.$15,382Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsCoreValve SURTAVI2021
2021-05-13Medtronic, Inc.$15,382Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsCoreValve SURTAVI2021
2021-05-13Abbott Laboratories$500Research paymentCash or cash equivalentXience V coronary stent system Device, VascularAbbott Vascular / XIENCE2021
2021-05-08PFIZER INC.$4,750Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPOLARIS PALBOCICLIB IN HORMONE RECEPTOR POSITIVE ADVANCED BREAST CANCER A PROSPECTIVE MULTICENTER NONINTERVENTIONAL STUD2021
2021-05-06Abbott Laboratories$250Research paymentCash or cash equivalentXience V coronary stent system Device, VascularAbbott Vascular / XIENCE2021
2021-05-03Genetesis, Inc.$8,560Research paymentCash or cash equivalentACCMED2021
2021-04-26Gilead Sciences, Inc.$1,832Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-04-22Abbott Laboratories$2,000Research paymentCash or cash equivalentQuadra Assura CRT Defibrillator Device, Cardiac Rhythm ManagementSt. Jude Medical Product Longevity and Performance (SCORE) Registry2021
2021-04-15Pharmacyclics LLC, an AbbVie Company$158Research paymentCash or cash equivalentIMBRUVICA Drug, ONCOLOGYinformCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)2021
2021-04-08ViiV Healthcare Company$6,335Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-04-08Penumbra, Inc.$390Research paymentCash or cash equivalentIndigo System Device, Peripheral InterventionCHEETAH2021
2021-04-03Abbott Laboratories$332Research paymentIn-kind items and services Device, Cardiac Rhythm ManagementLeadless II2021
2021-04-01JAZZ PHARMACEUTICALS INC.$186,733Research paymentIn-kind items and servicesVYXEOS Drug, HEMATOLOGY/ONCOLOGYA STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED A2021
2021-03-24ViiV Healthcare Company$101Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-03-24ViiV Healthcare Company$93Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-03-23Abbott Laboratories$600Research paymentCash or cash equivalentAbsorb GT1 Device, VascularA Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects2021
2021-03-17Gilead Sciences, Inc.$2,015Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-03-16Medtronic, Inc.$1,516Research paymentCash or cash equivalentTAVR Low Risk CAS2021
2021-03-16Medtronic, Inc.$1,516Research paymentCash or cash equivalentTAVR Low Risk CAS2021
2021-03-12Genetesis, Inc.$11,400Research paymentCash or cash equivalentACCMED2021
2021-03-12ViiV Healthcare Company$6,687Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-03-04Medtronic, Inc.$212Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-03-04Medtronic, Inc.$212Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-02-25ViiV Healthcare Company$9,908Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-02-18Penumbra, Inc.$2,177Research paymentCash or cash equivalentIndigo System Device, Peripheral InterventionCHEETAH2021
2021-02-17Gilead Sciences, Inc.$963Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-02-12Bard Peripheral Vascular, Inc.$10,000Research paymentCash or cash equivalentULTRASCORE Device, BD Interventional SurgeryUltraScore2021
2021-02-10Medtronic, Inc.$2,714Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsTAVR Low Risk2021
2021-02-10Medtronic, Inc.$2,714Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsTAVR Low Risk2021
2021-02-10Celgene Corporation$1,830Research paymentCash or cash equivalentRevlimid Drug, HematologyConnect MDS/AML2021
2021-02-10Abbott Laboratories$1,275Research paymentCash or cash equivalent Device, Cardiac Rhythm ManagementA safety and effectiveness trial for a leadless pacemaker system2021
2021-02-10Cardiovascular Systems Inc.$325Research paymentCash or cash equivalentDiamondback Coronary Device, Atherectomy DeviceECLIPSE2021
2021-02-09Medtronic, Inc.$4,000Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-02-09Medtronic, Inc.$4,000Research paymentCash or cash equivalentCoreValve Evolut Device, Transcatheter Valve SystemsOptimize Pro2021
2021-02-09Pharmacyclics LLC, an AbbVie Company$158Research paymentCash or cash equivalentIMBRUVICA Drug, ONCOLOGYinformCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)2021
2021-02-09Pharmacyclics LLC, an AbbVie Company$158Research paymentCash or cash equivalentIMBRUVICA Drug, ONCOLOGYinformCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)2021
2021-02-01ViiV Healthcare Company$5,000Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-02-01ViiV Healthcare Company$2,000Research paymentCash or cash equivalentA PHASE IIIB, RANDOMIZED, MULTICENTER, ACTIVE-CONTROLLED, PARALLEL-GRO2021
2021-01-29Abbott Laboratories$2,500Research paymentCash or cash equivalentDragonfly OCT Device, VascularSupporting Patients Undergoing HIgh-Risk PCI Using a High-Flow Percutaneous Left Ventricular Support Device (SHIELD II)2021
2021-01-26Abbott Laboratories$400Research paymentCash or cash equivalentXience V coronary stent system Device, VascularAbbott Vascular / XIENCE2021
2021-01-20Amgen Inc.$15,062Research paymentCash or cash equivalentRepatha Biological, Cardiology(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States2021
2021-01-20Gilead Sciences, Inc.$883Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2021
2021-01-14Pharmacyclics LLC, an AbbVie Company$158Research paymentCash or cash equivalentIMBRUVICA Drug, ONCOLOGYinformCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)2021
2021-01-12Cardiovascular Systems Inc.$500Research paymentCash or cash equivalentDiamondback Coronary Device, Atherectomy DeviceECLIPSE2021
2021-01-08Cardiovascular Systems Inc.$793Research paymentCash or cash equivalentDiamondback Coronary Device, Atherectomy DeviceECLIPSE2021
2021-01-01Biogen, Inc.$2,203Research paymentCash or cash equivalentPhase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Follo2021

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Wayne CountyDetroit city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Detroit, MI, county Wayne County, MI, state Michigan; placed by its city name.

MeasurePlace (city or town)
Detroit, MI
County
Wayne County, MI
State
Michigan
Population B01003638,5301,772,25910,077,761
Population, 2020 census P1639,1111,793,56110,077,331
Median age B0100235.237.940.2
Under 18 B0100124.8%23.6%21.2%
65 and over B0100115.1%16.6%18.6%
Households B11001257,998700,5914,076,369
Foreign born B050026.6%10.3%7.2%
Median household income B19013$39,938$60,539$72,875
Median family income B19113$49,398$79,522$93,357
Per capita income B19301$24,594$34,906$40,735
Poverty rate B1700132.7%20.8%13.2%
Unemployment rate B2302514.0%8.7%5.7%
Civilian labor force B23025268,955828,8385,018,449
Mean commute (minutes) B0801324.824.724.2
Bachelor's degree or higher B1500318.1%27.6%32.4%
Housing units B25001329,393801,0834,622,236
Owner-occupied B2500350.3%64.8%73.2%
Renters B2500349.7%35.2%26.8%
Median home value B25077$83,900$178,500$231,600
Median gross rent B25064$1,074$1,132$1,129
White, not Hispanic B0300210.8%47.9%72.4%
Black B0300275.0%36.6%13.1%
Hispanic or Latino B030028.3%6.9%5.9%
Asian B030021.7%3.7%3.4%
American Indian and Alaska Native B030020.2%0.2%0.3%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Detroit, MI.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.